Bed Bath & Beyond Inc. (NASDAQ:BBBY) was downgraded by research analysts at Wolfe Research from a “peer perform” rating to an “underperform” rating in a note issued to investors on Monday, MarketBeat Ratings reports.

Other research analysts have also issued reports about the stock. Zacks Investment Research raised shares of Bed Bath & Beyond from a “sell” rating to a “hold” rating in a report on Wednesday, March 15th. Loop Capital reissued a “sell” rating and issued a $35.00 target price on shares of Bed Bath & Beyond in a report on Thursday, March 30th. Wedbush cut their target price on shares of Bed Bath & Beyond from $42.00 to $38.00 and set a “neutral” rating for the company in a report on Thursday, April 6th. Credit Suisse Group cut their target price on shares of Bed Bath & Beyond from $39.00 to $38.00 and set a “neutral” rating for the company in a report on Friday, April 7th. Finally, ValuEngine lowered shares of Bed Bath & Beyond from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Eight investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $42.33.

Analyst Recommendations for Bed Bath & Beyond (NASDAQ:BBBY)

Bed Bath & Beyond (BBBY) traded down 0.51% during trading on Monday, reaching $35.15. 2,984,842 shares of the company’s stock were exchanged. The company has a market cap of $5.02 billion, a P/E ratio of 7.67 and a beta of 1.01. Bed Bath & Beyond has a 12-month low of $33.63 and a 12-month high of $48.83. The stock’s 50-day moving average is $35.87 and its 200-day moving average is $39.74.

Bed Bath & Beyond (NASDAQ:BBBY) last announced its quarterly earnings data on Wednesday, April 5th. The retailer reported $1.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.07. Bed Bath & Beyond had a net margin of 5.61% and a return on equity of 26.26%. The business had revenue of $3.53 billion during the quarter, compared to analyst estimates of $3.50 billion. During the same period last year, the firm posted $1.91 EPS. The company’s revenue was up 3.4% on a year-over-year basis. Analysts predict that Bed Bath & Beyond will post $4.32 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 18th. Stockholders of record on Friday, June 16th will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 1.71%. This is an increase from Bed Bath & Beyond’s previous quarterly dividend of $0.13. The ex-dividend date is Wednesday, June 14th. Bed Bath & Beyond’s dividend payout ratio (DPR) is 13.04%.

ILLEGAL ACTIVITY NOTICE: “Bed Bath & Beyond Inc. (BBBY) Lowered to “Underperform” at Wolfe Research” was first posted by American Banking News and is the property of of American Banking News. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://www.americanbankingnews.com/2017/06/19/bed-bath-beyond-inc-bbby-downgraded-by-wolfe-research.html.

In other news, CEO Steven H. Temares sold 96,109 shares of Bed Bath & Beyond stock in a transaction on Tuesday, May 9th. The stock was sold at an average price of $37.37, for a total transaction of $3,591,593.33. Following the completion of the sale, the chief executive officer now directly owns 629,415 shares in the company, valued at $23,521,238.55. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Arthur Stark sold 8,933 shares of Bed Bath & Beyond stock in a transaction on Friday, April 21st. The stock was sold at an average price of $39.73, for a total value of $354,908.09. Following the sale, the insider now owns 149,595 shares of the company’s stock, valued at $5,943,409.35. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 349,706 shares of company stock valued at $13,679,409. Corporate insiders own 5.00% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in BBBY. Guggenheim Capital LLC increased its stake in Bed Bath & Beyond by 31.2% in the fourth quarter. Guggenheim Capital LLC now owns 824,613 shares of the retailer’s stock valued at $33,512,000 after buying an additional 196,065 shares during the last quarter. Tudor Investment Corp Et Al increased its stake in Bed Bath & Beyond by 55.2% in the fourth quarter. Tudor Investment Corp Et Al now owns 32,299 shares of the retailer’s stock valued at $1,313,000 after buying an additional 11,487 shares during the last quarter. GSA Capital Partners LLP purchased a new stake in Bed Bath & Beyond during the fourth quarter valued at $597,000. Silvercrest Asset Management Group LLC increased its stake in Bed Bath & Beyond by 2.4% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 12,800 shares of the retailer’s stock valued at $520,000 after buying an additional 300 shares during the last quarter. Finally, Blenheim Capital Management BV purchased a new stake in Bed Bath & Beyond during the fourth quarter valued at $197,000. Hedge funds and other institutional investors own 92.45% of the company’s stock.

Bed Bath & Beyond Company Profile

Bed Bath & Beyond Inc is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market).

Receive News & Ratings for Bed Bath & Beyond Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bed Bath & Beyond Inc. and related companies with MarketBeat.com's FREE daily email newsletter.